Literature DB >> 9973156

Long-term outcomes of an arthritis self-management programme.

J H Barlow1, A P Turner, C C Wright.   

Abstract

OBJECTIVE: A previous UK evaluation of the Arthritis Self-Management Programme (ASMP) demonstrated 4 month improvements in physical and psychological well-being including increased arthritis self-efficacy and increased use of self-management behaviours such as cognitive symptom management, and reductions in pain, fatigue and anxiety. The purpose of this study was to determine whether these effects were maintained at 12 month follow-up.
METHODS: Twelve month data were collected via self-administered questionnaires mailed to participants who had previously responded prior to attending the ASMP and at 4 months follow-up.
RESULTS: The sample (n = 112) comprised 82% women with a mean age of 59.6 (S.D. 12.4) yr and a mean disease duration of 14.9 (S.D. 11.1) yr. The majority of participants had a general practitioner-recorded diagnosis of either rheumatoid arthritis (46%) or osteoarthritis (44%). Many of the changes noted at 4 months were sustained at the 12 month follow-up.
CONCLUSION: This first long-term evaluation of a community-based patient education intervention delivered in the UK suggests that after participation in the ASMP, persons with arthritis derive substantial and prolonged benefits in terms of perceived ability to manage arthritis, reduction in pain and improved psychological well-being.

Entities:  

Mesh:

Year:  1998        PMID: 9973156     DOI: 10.1093/rheumatology/37.12.1315

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  25 in total

Review 1.  Nonpharmacologic therapy of osteoarthritis.

Authors:  P J Perkins; M Doherty
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 2.  Acknowledging the expertise of patients and their organisations.

Authors:  J Wilson
Journal:  BMJ       Date:  1999-09-18

3.  Exploring the role of self-management programmes in caring for people from culturally and linguistically diverse backgrounds in Melbourne, Australia.

Authors:  Christine Walker; Amanda Weeks; Brian McAvoy; Elsa Demetriou
Journal:  Health Expect       Date:  2005-12       Impact factor: 3.377

4.  Myofascial Pain Syndrome in the Elderly and Self-Exercise: A Single-Blind, Randomized, Controlled Trial.

Authors:  Minhee Kim; Minyoung Lee; Yushin Kim; Sejun Oh; Dongshin Lee; BumChul Yoon
Journal:  J Altern Complement Med       Date:  2016-02-24       Impact factor: 2.579

5.  Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial.

Authors:  J Hill; H Bird; S Johnson
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

6.  Barriers to patient information provision in primary care: patients' and general practitioners' experiences and expectations of information for low back pain.

Authors:  Aileen McIntosh; Clare F M Shaw
Journal:  Health Expect       Date:  2003-03       Impact factor: 3.377

7.  The UK Expert Patients Program: lessons learned and implications for cancer survivors' self-care support programs.

Authors:  Patricia M Wilson
Journal:  J Cancer Surviv       Date:  2008-03       Impact factor: 4.442

8.  Facilitators and Barriers to Participation in a Peer Support Intervention for Veterans With Chronic Pain.

Authors:  Marianne S Matthias; Marina Kukla; Alan B McGuire; Teresa M Damush; Nabiha Gill; Matthew J Bair
Journal:  Clin J Pain       Date:  2016-06       Impact factor: 3.442

9.  Encouraging patients to self-care - the preliminary development and validation of the VeLUSET©, a self-efficacy tool for venous leg ulcer patients, aged 60 years and over.

Authors:  Annemarie Brown; Sally Kendall; Madeleine Flanagan; Michaela Cottee
Journal:  Int Wound J       Date:  2013-12-26       Impact factor: 3.315

10.  Effectiveness of two Arthritis Foundation programs: Walk With Ease, and YOU Can Break the Pain Cycle.

Authors:  Michelle Bruno; Susan Cummins; Lisha Gaudiano; Johanna Stoos; Peter Blanpied
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.